Hannah Milward is currently seeking to recruit a Process Improvement Manager to join a major healthcare organisation.
The job:
As a Process Improvement Manager you will provide focus on the development of new and existing processes. By building quality in to the process design, the products will be produced in the most efficient way and meet the customer and regulatory needs.
Responsibilities:
As a Process Improvement Manager you will be responsible for leading the Process Improvement Team to provide an efficient service to optimise manufacturing and cleaning processes using a quality by design approach whilst ensuring the validation activities meet Regulatory and Customer requirements.
The job holder will need to provide an effective New Product Introduction service for Clinical Trial clients to ensure new products are introduced successfully and that the processes are developed and validated to ensure the required levels of product quality and regulatory compliance are met. You will also need to deliver a comprehensive process, equipment and cleaning validation programme in accordance with cGMP and Customer requirements.
Qualifications and skills:
To be considered for this Process Improvement Manager position you will have:
Previous experience in the development or manufacture of healthcare products with a proven track record of new product introduction which is critical to this role.
In depth knowledge of cGMP, multiple dosage forms with an emphasis on sterile products and an awareness of Unlicensed and Licensed Legislation are key to your success in this role.
Previous leadership and management skills would be an advantage.
You will also enjoy working cross functionally in a fast paced environment with teams of diverse people, have a can do attitude with the capability to plan and see the bigger picture, excellent Leadership and Customer Service skills and the ability to influence and build relationships at all levels across the business.
How to apply:
For more information or to apply for this role please contact Hannah Milward on 0114 283 9956 or email hmilward@ckscience.co.uk. Please quote reference SH23326 in all correspondence.
Hannah Milward is currently seeking to recruit a Process Improvement Manager to join a major healthcare organisation in the East Midlands.
Responsibilities:
As Process Improvement Manager you will provide focus on the development of new and existing processes. By building quality in to the process design, the products will be produced in the most efficient way and meet the customer and regulatory needs.
You will be responsible for leading the Process Improvement Team to provide an efficient service to optimise manufacturing and cleaning processes using a Quality by Design approach whilst ensuring the validation activities meet Regulatory and Customer requirements.
The job holder will need to provide an effective New Product Introduction service for Clinical Trial clients to ensure new products are introduced successfully and that the processes are developed and validated to ensure the required levels of product quality and regulatory compliance are met. You will also need to deliver a comprehensive process, equipment and cleaning validation programme in accordance with cGMP and Customer requirements.
Qualifications & skills required:
To be considered for this Process Improvement Manager position you will have previous experience in the development or manufacture of healthcare products with a proven track record of new product introduction is critical to this role. In depth knowledge of cGMP, multiple dosage forms with an emphasis on sterile products and an awareness of Unlicensed and Licensed Legislation are key to your success in this role and previous leadership and management skills would be an advantage.
You will enjoy working cross functionally in a fast paced environment with teams of diverse people, have a can do attitude with the capability to plan and see the bigger picture, excellent Leadership and Customer Service skills and the ability to influence and build relationships at all levels across the business.
How to apply:
For more information or to apply for this Process Improvement Manager role please contact Hannah Milward on 0114 2839956 or email hmilward@ckscience.co.uk. Please quote reference SH23326 in all correspondence.
Hannah Milward at CK Science presents this week’s Job of the Week, a Process Improvement Manager role in the East Midlands. To find out more, please watch Hannah’s short video and read the job description below:
Process Improvement Manager: Job Description
Our client, a major Healthcare organisation is currently recruiting for a Process Improvement Manager to join their team based in the East Midlands.
As Process Improvement Manager you will provide focus on the development of new and existing processes. By building quality in to the process design our products will be produced in the most efficient way and meet the customer and regulatory needs.
You will also be responsible for leading the Process Improvement Team to provide an efficient service to optimise manufacturing and cleaning processes using a Quality By Design approach whilst ensuring the validation activities meet Regulatory and Customer requirements.
As Process Improvement Manager, you will need to provide an effective New Product Introduction service for Clinical Trial clients to ensure new products are introduced successfully and that the processes are developed and validated to ensure the required levels of product quality and regulatory compliance are met. You will also need to deliver a comprehensive process, equipment and cleaning validation programme in accordance with cGMP and Customer requirements.
The ideal candidate:
To be considered for this Process Improvement Manager role, you will have previous experience in the development or manufacture of healthcare products with a proven track record of new product introduction is critical to this role. In depth knowledge of cGMP, multiple dosage forms with an emphasis on sterile products and an awareness of Unlicensed and Licensed Legislation are key to your success in this role and previous leadership and management skills would be an advantage.
As Process Improvement Manager, you will enjoy working cross functionally in a fast paced environment with teams of diverse people, have a can do attitude with the capability to plan and see the bigger picture, excellent Leadership and Customer Service skills and the ability to influence and build relationships at all levels across the business.
How to apply:
For more information or to apply for this Process Improvement Manager position, please contact Hannah Milward on +44 (0) 114 283 9956 or email hmilward@ckscience.co.uk. Please quote reference SH23326 in all correspondence.
Barney Smith is currently looking for a Shift Manager to join a world leading manufacturer at their site in Scotland.
The Job:
The successful candidate for this Shift Manager role will report to the Operations manager. The company require a manager to oversee the manufacturing team working continental 6 on, 4 off. This is an excellent opportunity to work in an influential role within one of the world’s leading manufacturing companies.
Responsibilities:
As a Shift Manager you will be responsible for total leadership of the shift operation including using effective staff resourcing, ensuring maximum production output levels, maintenance of high quality product standards and customer expectations, and be instrumental in continuous improvement initiatives.
Qualifications and Skills:
The ideal candidate must have a proven track record working within a food manufacturing environment at supervisory or management level and be entitled to work in the UK.
How to apply:
For more information or to apply for this Shift Manager role please contact Barney Smith on 0191 384 8905 or email bsmith@ckscience.co.uk. Please quote reference DH22907 in all correspondence.
BP are to redevelop their North Sea oil fields, securing and creating jobs in the process, reports the Guardian.
This is despite the Chancellor’s announcement of a £2 billion levy on North Sea oil and gas, to ease petrol prices, threatening the £12 billion investment and the expected creation of 15,000 jobs. Bob Dudley, BP’s chief executive, has said that the investment is due to the “extensive knowledge” BP has of the North Sea due to over “forty years experience.”
The Treasury has claimed that BP’s decision shows that the North Sea is an “attractive area for new levels of investment.” Despite a drop in offshore drilling of 52% in the second quarter, for a variety of reasons including the government’s budget, the investment is set to go ahead, keeping the offshore platforms running until 2035 at least.
Business Secretary Vince Cable has opened the Norwich Research Park, set to create 5,000 jobs, reports EDP24.com.
Mr Cable praised the park, calling it “world beating” and “ambitious” as he opened the facility equipped with office space and laboratories. The area the park has been built in is one with a high concentration of food and environmental science businesses, and the project is expected to create around 5,000 jobs over the next fifteen years.
Mr Cable reaffirmed the government’s commitment to the science industry by agreeing to a £26 million investment into the Norwich Research Park, as business plans have been submitted to the government. The park is expected to create the jobs by expanding thanks to the investment.
The investment is expected to create up to 1,000 jobs in one of four UK plants, with Montrose thought to be the front runner due to the recent movement of biomanufacturing of several products from India to the Montrose plant. The Montrose factory also manufactures the products needed to make products that GSK inherited following its acquisition of Steifel in 2009.
Andrew Witty, GSK chief executive, praised the 280 staff at the Montrose factory for turning around what was an ailing site, up for sale at the turn of the Millennium, into a “globally competitive” production plant.
Biopharmaceutical company Quintiles is looking to establish more UK sites, creating pharmaceutical and clinical jobs, reports pharmatimes.com.
The US company sees the UK as a good place for clinical trials and is hoping to open at least two more Prime Sites to go alongside the one at Queen Mary, University of London. Including two other current sites, Quintiles employs 2,000 people in the UK, a figure set to rise with the planned opening of the new Prime Sites.
Lindy Jones, Quintiles head of global integrated site services, says the UK is of “significant interested to us,” with fifty trials currently being run at the Queen Mary site. Jones believe that the UK “has opened up far more to clinical research” in the past eighteen months, meaning that Quintiles is considering opening “an additional two, maybe three Prime Sites in the UK.”
A science park in Runcorn is bidding to win Enterprise status and create thousands of jobs, reports runcornandwidnesworld.co.uk.
If the Daresbury Science and Innovation Park is granted this status, then it could generate up to 10,000 skilled jobs and lead to £150 million investment. Holton Council leader Clr Rob Polhill has said the status would “take Daresbury to the next level.”
Around 100 companies have offices, workshops and laboratories on the site, and the massive investment would mean that even more specialist office, lab and technical spaces would be developed. The site opened in 2006 and is a world class centre for cutting edge sciences and high-tech businesses.
Pharmaceutical companyPfizer’s decision to separate certain divisions could lead to a larger break up in order for further growth, including in employment, reports forbes.com.
The splitting of the animal health and baby formula businesses from the main company is the beginning of a process to unlock value within the company. Two other sectors will be kept in order to raise their value to $46 billion combined, though investors had hoped the company would split into five distinct divisions.
The two that have broken off were the obvious choices; the animal health business is worth nearly $4 billion so can stand on its own, and the nutrition side is the one that investors were most eager to see separate.
Though some investors may be disappointed that Pfizer hasn’t split all its divisions at once, it means that sectors that could not currently compete on their own have time to grow to the point where they can be world leaders in their own right, potentially creating a large number of jobs worldwide.
